cells-i-treefrog-therapeutics Videos
13 videos found
A quick overview of C-Stem™, the patented technology operated by TreeFrog Therapeutics to mass-produce stem cells for cell ...
Jul. 13, 2022
TreeFrog Therapeutics is a stem cell company based in Bordeaux, France, that will enable millions of patients to access the medical revolution of cell therapy by overcoming its main manufacturing ...
Jul. 13, 2022
Highlighting the progress made by Kris Boesen and Lucas Lindner, both of whom received Lineage's OPC1 cell therapy following traumatic spinal cord injury ...
Jul. 15, 2022
Ali Tehrani is the co-founder and CEO of Zymeworks, one of the most successful biotech companies to emerge from Vancouver. He sits down to talk about the history of his company, going public and the challenges ahead for startups in B.C.'s life sciences sector. Tyler Orton ...
Jun. 18, 2022
Short white-board video explaining the APOSEC story: paradigm change from stem cells to paracrine factors derived from white blood cells as therapeutic agent in regenerative medicine ...
Sep. 3, 2021
Adipose tissue derived stem cell therapeutic product for ...
Jun. 3, 2022
See how the SCI-tive hypoxia workstation makes a difference to Prof. Nicholas Forsyth from Keele University as he works with mesenchymal stem cells. ...
Apr. 18, 2020
ByBaker
Pluristem's cell manufacturing technology - PLX Bioreactor 3D system, is integrated into the world’s most advanced, automated and aseptic cell production facility, in which we can manufacture large quantities of cells of the highest quality in a cost-effective, reproducible and consistent manner. This capability is necessary for any cell therapy to become a true commercial product. ...
May. 31, 2022
Cell therapy company TreeFrog Therapeutics is powering The Stem Cell SpaceShot Grant - a $100,000 research funding in the field of stem cell biology and regenerative medicine. It’s open to PhD-level scientists and PhD students conducting research in stem cell biology, biophysics, gene editing, cell therapy, and bioproduction engineering. Applications are opened from May 1st until June 30th ...
Jul. 13, 2022
From discovery research to clinical evaluation, Champions Oncology combines innovative technology and unrivaled expertise to enable more efficient drug discovery and development workflow. Our data-driven research platforms empower scientists to create a comprehensive understanding of tumor cell biology, therapeutic dynamics and provide rapid clinical ...
Feb. 1, 2023
Incorporated in Bordeaux, France, in 2018, TreeFrog Therapeutics aims to provide access to safe and affordable cell therapies for millions of patients. TreeFrog Therapeutics has developed C-Stem™, a high-throughput cell encapsulation technology allowing for the mass-production and differentiation of stem cells in industrial bioreactors. Currently expanding in the US and Japan, TreeFrog is ...
Jul. 13, 2022
Pluristem presents topline Phase I results from its hematology program, which is the first to study PLX-R18 in humans. The video provides first-hand interviews from Dr. Nitsan Halevy, Chief Medical Officer, and Dr. Racheli Ofir, VP Research & Intellectual Property, sharing insights on PLX-R18’s unique mechanism of action and therapeutic potential for the treatment of hematology deficiencies. ...
May. 31, 2022